Skip to main content

Izervay Side Effects

Generic name: avacincaptad pegol ophthalmic

Medically reviewed by Drugs.com. Last updated on Sep 8, 2023.

Note: This document contains side effect information about avacincaptad pegol ophthalmic. Some dosage forms listed on this page may not apply to the brand name Izervay.

Applies to avacincaptad pegol ophthalmic: intraocular solution.

Serious side effects of Izervay

Along with its needed effects, avacincaptad pegol ophthalmic (the active ingredient contained in Izervay) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking avacincaptad pegol ophthalmic:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to avacincaptad pegol ophthalmic: intravitreal solution.

General

The most frequently reported side effects included conjunctival hemorrhage (13%), increased intraocular pressure (IOP) (9%), blurred vision (8%) and neovascular age-related macular degeneration (7%).[Ref]

Ocular

Very common (10% or more): Conjunctival hemorrhage (13%)

Common (1% to 10%): Increased intraocular pressure, blurred vision, choroidal neovascularization, eye pain, vitreous floaters, blepharitis

Frequency not reported: Ocular infection, periocular infection, active intraocular inflammation, endophthalmitis, retinal detachments, neovascular AMD[Ref]

Blurred vision includes visual impairment, blurred vision, reduced visual acuity, and transiently reduced visual acuity.[Ref]

References

1. Product Information. Izervay (avacincaptad pegol). IVERIC Bio, Inc. 2023.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.